Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Child Abuse Negl ; 118: 105154, 2021 08.
Article in English | MEDLINE | ID: mdl-34147941

ABSTRACT

BACKGROUND: Experience of childhood abuse has been suggested to increase the severity of post-traumatic stress disorder (PTSD) in adulthood. We hypothesized that resilience and coping strategies, which could be altered by experiencing childhood abuse, may mediate the effects of childhood abuse on PTSD severity in adulthood. METHODS: Crime victims with PTSD (n = 212, 38 men, aged 20-65 years) were recruited from South Korea. PTSD severity, a history of childhood abuse, resilience level, and use of coping strategies were assessed using structured clinical interviews and self-report questionnaires. Upon identifying the key factors that were associated with childhood abuse and PTSD severity, mediating roles of these key factors were examined using structural equation modeling and bootstrapping in simple and multiple mediation analyses. RESULTS: Resilience and dysfunctional coping strategies mediated the association between childhood abuse and lifetime PTSD severity in the adulthood, after covarying for the number of repeated trauma exposure (total effect: ß = 0.44, P = 0.01, 95% CI [0.10, 0.77]; direct effect: ß = 0.02, P = 0.90, 95% CI [-0.34, 0.38]; indirect effect: ß = 0.42, P = 0.003, 95% CI [0.14, 0.69]). LIMITATIONS: Recall of childhood abuse experience and lifetime PTSD severity can be biased in crime victims. CONCLUSIONS: These findings may suggest that resilience and coping strategies mediate the detrimental effects of childhood abuse on lifetime PTSD severity. Targeted treatments that are designed to enhance resilience as well as deter the use of dysfunctional coping strategies may be of help in crime victims with a history of childhood abuse.


Subject(s)
Child Abuse , Crime Victims , Stress Disorders, Post-Traumatic , Adaptation, Psychological , Adult , Child , Humans , Male , Stress Disorders, Post-Traumatic/epidemiology , Surveys and Questionnaires
2.
Front Psychol ; 12: 569113, 2021.
Article in English | MEDLINE | ID: mdl-33927662

ABSTRACT

Computerized relaxation training has been suggested as an effective and easily accessible intervention for individuals with psychological distress. To better elucidate the neural mechanism that underpins the effects of relaxation training, we investigated whether a 10-session computerized relaxation training program changed prefrontal gamma-aminobutyric acid (GABA) levels and cerebral blood flow (CBF) in women with psychological distress. We specifically focused on women since they were reported to be more vulnerable to develop stress-related disorders than men. Nineteen women with psychological distress but without a diagnosis of psychiatric disorders received the 10-day computerized relaxation training program that consisted of 30-min cognitive-relaxation training and 10-min breathing-relaxation training per day. At baseline and post-intervention, perceived stress levels, anxiety, fatigue, and sleep quality were assessed by self-report questionnaires. Brain magnetic resonance spectroscopy and arterial spin labeling scans were also performed before and after the intervention to evaluate GABA levels and relative CBF in the prefrontal region. Levels of perceived stress (t = 4.02, P < 0.001), anxiety (z = 2.33, P = 0.02), fatigue (t = 3.35, P = 0.004), and sleep quality (t = 4.14, P < 0.001) improved following 10 sessions of computerized relaxation training, resulting in a significant relief in composite scores of stress-related symptoms (t = -5.25, P < 0.001). The prefrontal GABA levels decreased (t = 2.53, P = 0.02), while relative CBF increased (t = -3.32, P = 0.004) after the intervention. In addition, a greater increase in relative prefrontal CBF was associated with better composite scores of stress-related symptoms following the intervention (t = 2.22, P = 0.04). The current findings suggest that computerized relaxation training may improve stress-related symptoms through modulating the prefrontal GABA levels and CBF in women with psychological distress.

3.
Neurol Sci ; 42(10): 4131-4138, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33532950

ABSTRACT

BACKGROUND: Recent evidence suggests that hyperbaric oxygenation (HBO), which has been used as an effective treatment for certain types of tissue injury, may change neural activities in the human brain and subsequently improve symptoms of psychiatric disorders. To scrutinize the neural mechanism of HBO in the human brain, we investigated whether 20 sessions of HBO changed regional cerebral blood flow (rCBF) of the limbic system in firefighters with mild traumatic brain injury (mTBI) and subjective emotional distress. METHODS: Twenty firefighters with mTBI and mild emotional distress were treated with HBO at a relatively low pressure of 1.3 atmospheres absolute for 45 min a day for 20 consecutive days (the mild emotional distress group). The rCBF of the limbic system was measured using an arterial spin labeling perfusion magnetic resonance imaging before and after the HBO. Analyses were performed on the data from fourteen individuals who completed the study and 14 age- and sex-matched healthy firefighters (the comparison group). RESULTS: Firefighters in the mild emotional distress group showed increase rCBF following HBO in a cluster encompassing the right hippocampal and parahippocampal regions (peak t = 4.31; cluster size = 248 mm3)(post-hoc analysis, z = 5.92, p < 0.001) that had lower rCBF relative to the comparison group at baseline (post-hoc analysis, t = -2.20, p = 0.04). CONCLUSION: The current study demonstrated that low-pressure HBO might increase rCBF of the hippocampal and parahippocampal regions, suggesting a potential underpinning mechanism of HBO in the human brain.


Subject(s)
Brain Concussion , Firefighters , Hyperbaric Oxygenation , Psychological Distress , Cerebrovascular Circulation , Hippocampus/diagnostic imaging , Humans
4.
Hum Psychopharmacol ; 36(2): e2767, 2021 03.
Article in English | MEDLINE | ID: mdl-33217050

ABSTRACT

OBJECTIVE: We aimed to investigate the effects of Korean red ginseng (KRG) supplementation on gray matter volume of the human brain which could be related to cognitive enhancing effects of KRG. METHODS: In this randomized, double-blind, placebo-controlled study, 51 healthy individuals were assigned to receive either KRG (1000 mg/day, n = 26) or placebo (n = 25) for 8 weeks. Gray matter volume of the whole brain was measured using voxel-based morphometry based on high-resolution T1-weighted magnetic resonance images acquired at baseline and week 8. The standardized composite cognitive scores of executive function, attention, and memory were also evaluated at baseline and week 8. Changes in gray matter volume as well as the composite cognitive scores were compared between the KRG and placebo groups. RESULTS: Following 8 weeks of KRG supplementation, the gray matter volume of the left parahippocampal gyrus increased significantly in the KRG group, relative to the placebo group (p for interaction < 0.001). The KRG group also showed greater magnitude of enhancement in the composite cognitive scores relative to the placebo group (p for interaction = 0.03). CONCLUSIONS: Gray matter volume increase in the parahippocampus may be a key neural change as induced by KRG supplementation, which could be associated with cognitive enhancement.


Subject(s)
Panax , Brain/diagnostic imaging , Cognition , Gray Matter/diagnostic imaging , Humans , Magnetic Resonance Imaging
5.
Sleep Med ; 74: 66-72, 2020 10.
Article in English | MEDLINE | ID: mdl-32841846

ABSTRACT

BACKGROUND: Bright light (BL) exposure is a safe non-pharmacological intervention for sleep disturbances. However, the functional brain correlates underlying the effects of bright light exposure need to be further clarified. As alterations in the salience network were reported in individuals with sleep disturbances, we have investigated whether bright light exposure may improve sleep quality by altering functional connectivity in this network. METHODS: In the current study, 30 individuals with sleep disturbances were randomly assigned to one of the two interventions for two weeks: (1) 1 h of bright light (10,000 lux) exposure (BL-exposed group) and (2) 1 h of dim light (<300 lux) exposure (DL-exposed group). Sleep characteristics and functional connectivity in the salience network were assessed by sleep diary and resting-state functional magnetic resonance imaging, respectively, as outcome measures at before and after the intervention. RESULTS: After two weeks of the intervention, the BL-exposed group showed greater improvement with respect to sleep efficiency (t = 2.27, p = 0.03) and sleep latency (t = -2.40, p = 0.03) as compared to the DL-exposed group. In addition, functional connectivity decreased in the cluster that encompasses the right anterior insular and the frontal opercular regions in the salience network (uncorrected p < 0.001, cluster size>100 mm3) in the BL-exposed group. Decreased functional connectivity in the cluster was associated with decreased sleep latency in the BL-exposed group (ß = 0.54, p = 0.01). CONCLUSIONS: Our results suggest that bright light exposure may improve sleep quality in individuals with sleep disturbances by modulating functional connectivity in the salience network. CLINICAL TRIAL REGISTRATION: https://cris.nih.go.kr/cris; KCT0002607.


Subject(s)
Sleep Wake Disorders , Cerebral Cortex , Frontal Lobe , Humans , Light , Magnetic Resonance Imaging , Sleep , Sleep Wake Disorders/therapy
6.
Front Syst Neurosci ; 14: 9, 2020.
Article in English | MEDLINE | ID: mdl-32194378

ABSTRACT

The propensity to engage in risky behaviors including excessive alcohol consumption may impose increased medical, emotional, and psychosocial burdens. Personality and behavioral traits of individuals may contribute in part to the involvement in risky behaviors, and therefore the classification of one's traits may help identify those who are at risk for future onset of the addictive disorder and related behavioral issues such as alcohol misuse. Personality and behavioral characteristics including impulsivity, anger, reward sensitivity, and avoidance were assessed in a large sample of healthy young adults (n = 475). Participants also underwent diffusion tensor imaging for the analysis of structural brain networks. A data-driven clustering using personality and behavioral traits of the participants identified four subtypes. As compared with individuals clustered into the neutral type, individuals with a high level of impulsivity (A subtype) and those with high levels of reward sensitivity, impulsivity, anger, and avoidance (B subtype) showed significant associations with problem drinking. In contrast, individuals with high levels of impulsivity, anger, and avoidance but not reward sensitivity (C subtype) showed a pattern of social drinking that was similar to those of the neutral subtype. Furthermore, logistic regression analysis with ridge estimators was applied to demonstrate the neurobiological relevance for the identified subtypes according to distinct patterns of structural brain connectivity within the addiction circuitry [neutral vs. A subtype, the area under the receiver operator characteristic curve (AUC) = 0.74, 95% CI = 0.67-0.81; neutral vs. B subtype, AUC = 0.74, 95% CI = 0.66-0.82; neutral vs. C subtype, AUC = 0.77, 95% CI = 0.70-0.84]. The current findings enable the characterization of individuals according to subtypes based on personality and behavioral traits that are also corroborated by neuroimaging data and may provide a platform to better predict individual risks for addictive disorders.

7.
Sci Rep ; 9(1): 15539, 2019 10 29.
Article in English | MEDLINE | ID: mdl-31664062

ABSTRACT

Distinct brain alterations in response to traumatic events may render trauma-exposed individuals either resilient or vulnerable to posttraumatic stress disorder (PTSD). This study compared regional cerebral metabolic rate of glucose (rCMRglu) among trauma-exposed individuals with current PTSD (PTSD group, n = 61), those without current PTSD (Resilience/Recovery group, n = 26), and trauma-unexposed controls (Control group, n = 54). All participants underwent brain [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) scans. Voxel-wise group differences in rCMRglu among the three groups were evaluated. Associations between rCMRglu and both PTSD severity and resilience were examined. The rCMRglu in the right anterior insula and adjacent prefrontal and striatal areas was lower in the PTSD group, while higher in the Resilience/Recovery group, compared to the Control group. In addition, the lower glucose metabolism of these areas was associated with higher severity and less improvement in PTSD symptoms in the PTSD group, while the higher levels of rCMRglu were correlated with stronger resilience in the Resilience/Recovery group. This study suggests distinct roles of the anterior insula in response to trauma between the PTSD and Resilience/Recovery groups. Heightened rCMRglu in the anterior insular regions may reflect an underlying mechanism of resilience against traumatic stress, while reduced rCMRglu may indicate vulnerability to PTSD.


Subject(s)
Cerebral Cortex , Glucose/metabolism , Positron-Emission Tomography , Stress Disorders, Post-Traumatic , Wounds and Injuries , Adult , Aged , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/metabolism , Female , Humans , Male , Middle Aged , Stress Disorders, Post-Traumatic/diagnostic imaging , Stress Disorders, Post-Traumatic/metabolism , Wounds and Injuries/diagnostic imaging , Wounds and Injuries/metabolism
8.
Nutrients ; 11(8)2019 Jul 25.
Article in English | MEDLINE | ID: mdl-31349690

ABSTRACT

Polygonatum sibiricum (PS) rhizome, which contains glyceryl-1-monolinoleate as its primary active component, has been shown to improve insomnia in animal models. Based on these findings, we aimed to investigate the safety and efficacy of PS rhizome extract in improving sleep quality in individuals with mild insomnia. Eighty individuals with mild insomnia were enrolled in a four-week, randomized, double-blind, placebo-controlled trial of PS rhizome extract (500 mg/day, n = 40, PS group) or placebo (n = 40, placebo group). The primary outcome measure was change in total score on the Athens Insomnia Scale (AIS) to indicate sleep quality. The secondary outcome measures included change in actigraphy data and perfusion levels in the brain regions within the default mode network (DMN), which is known to play a key role in insomnia. The PS group showed greater improvement in the total AIS score with a significant increase in total sleep time, relative to the placebo group. In addition, significant group-by-visit interactions were observed in the perfusion level of the medial prefrontal cortex within the DMN. Findings of the current study provide first evidence that PS rhizome extract could be an effective natural ingredient for improving sleep in mild insomnia using a human model.


Subject(s)
Plant Extracts/therapeutic use , Polygonatum , Sleep Aids, Pharmaceutical/therapeutic use , Sleep Initiation and Maintenance Disorders/drug therapy , Sleep/drug effects , Adult , Double-Blind Method , Female , Humans , Male , Middle Aged , Plant Extracts/adverse effects , Plant Extracts/isolation & purification , Polygonatum/chemistry , Rhizome , Seoul , Severity of Illness Index , Sleep Aids, Pharmaceutical/adverse effects , Sleep Aids, Pharmaceutical/isolation & purification , Sleep Initiation and Maintenance Disorders/diagnosis , Sleep Initiation and Maintenance Disorders/physiopathology , Time Factors , Treatment Outcome
9.
Exp Neurobiol ; 28(1): 1-16, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30853820

ABSTRACT

Cognitive enhancement refers to the improvement of cognitive function related to deficits that occurred as part of a certain illness. However, the term cognitive enhancement does not yet have a definitive meaning, and its connotations often vary depending on the research of interest. Recently, research interests are growing towards enhancing human cognition beyond what has traditionally been considered necessary using various brain devices. The phenomenon of exceeding the cognitive abilities of individuals who are already functional has also introduced new terminologies as means to classify between cognitive enhancing procedures that are part of treatment versus simply supplementary. Of the many devices used to attain cognitive enhancement, transcranial magnetic stimulation (TMS) is a unique neurostimulatory device that has demonstrated significant improvements in various cognitive domains including memory and cognitive processing skills. While many studies have supported the safety and efficacy of TMS in treatment, there has yet to be an optimization in parameter for TMS that is catered to a certain target group. The current paper aims to review with perspective the many studies that have used TMS for the purpose of cognitive enhancement and provide further insight on the development of an optimal stimulation parameter. The paper reviews 41 peer-reviewed articles that used TMS for cognitive enhancement, summarizes the findings that were apparent for each distinct parameter, and discusses future directions regarding TMS as an elective tool for healthy individuals while considering some of the ethical perspectives that may be warranted.

10.
Nutrients ; 11(2)2019 Feb 01.
Article in English | MEDLINE | ID: mdl-30717153

ABSTRACT

Early intervention using dietary supplements may be effective in alleviating cognitive impairment among individuals with mild cognitive impairment (MCI). This study investigated the efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) as a nutritional supplement for cognitive enhancement. One hundred individuals with MCI were randomly assigned to take DW2009 (800 mg/day, n = 50) or placebo (800 mg/day, n = 50) for 12 weeks. The primary outcome measure was change in the composite score of cognitive functions related to memory and attention, measured by computerized neurocognitive function tests. Associations between changes in serum brain-derived neurotrophic factor (BDNF) levels and cognitive performance for each treatment group were evaluated. Compared to the placebo group, the DW2009 group showed greater improvements in the combined cognitive functions (z = 2.36, p for interaction = 0.02), especially in the attention domain (z = 2.34, p for interaction = 0.02). Cognitive improvement was associated with increased serum BDNF levels after consumption of DW2009 (t = 2.83, p = 0.007). The results of this clinical trial suggest that DW2009 can be safely administered to enhance cognitive function in individuals with MCI. Increased serum BDNF levels after administering DW2009 may provide preliminary insight into the underlying effects of cognitive improvement, which suggests the importance of the gut-brain axis in ameliorating cognitive deficits in MCI.


Subject(s)
Cognitive Dysfunction/diet therapy , Lactobacillus plantarum , Probiotics/therapeutic use , Soy Foods , Aged , Brain-Derived Neurotrophic Factor/blood , Cognitive Dysfunction/physiopathology , Double-Blind Method , Feces/microbiology , Female , Gastrointestinal Microbiome , Humans , Male , Middle Aged , Probiotics/adverse effects , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...